GOLDENWELL BIOTECH, INC. (GWLL) Gross margin 2021–2025
GOLDENWELL BIOTECH, INC. (GWLL) gross margin by fiscal year — reported gross profit divided by reported revenue.
21.8%FY2025 · since FY2021: 52.5% → 21.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 21.8% | -24.2 pp |
| FY2024 | 46.0% | +17.6 pp |
| FY2023 | 28.5% | -24.2 pp |
| FY2022 | 52.7% | +0.2 pp |
| FY2021 | 52.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GWLL financial trends
GWLL RevenueGWLL Net incomeGWLL Net marginGWLL Gross profitGWLL Operating incomeGWLL Operating marginGWLL Operating cash flowGWLL Free cash flowGWLL Capital expendituresGWLL Return on equityGWLL Stock buybacksGWLL Dividends paidGWLL Total assetsGWLL Total liabilitiesGWLL Shareholders’ equityGWLL overview →